http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200105299-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b02a0b178545b772f5459d938a584583 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0047 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1eb19506e0e3b13226e567f34c223ee |
publicationDate | 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20200105299-A |
titleOfInvention | Ultrasound-driven drug delivery platforms by the use of nanobubbles water prepared with drug-conjugated phospholipids via ester bonds and preparation method thereof |
abstract | The present invention relates to a phospholipid-based drug delivery system to which a drug is bound through a linker containing an ester bond, a composition for drug delivery comprising the drug delivery system and nanobubble water, a method for preparing the phospholipid-based drug delivery system, and the composition to a human It relates to a method for preventing or treating diseases comprising the step of administering to an individual except for the step of releasing a drug by irradiating ultrasound to a site to which the composition is administered. When the drug delivery system of the present invention is administered to an individual in a form dissolved in nanobubble water, the hydrolysis of the ester bond is smoothly performed according to the ultrasonic irradiation, thereby synergistically increasing the release rate of the target drug. The target drug can be delivered. |
priorityDate | 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.